AKUMS DRUGS AND PHARMA L
NSE: AKUMS · Healthcare
₹745.05
-25.30 (-3.28%)
Last close · 30 Aug 2026, 2:51 am IST
- Open
- ₹776.50
- Day high
- ₹783.00
- Day low
- ₹744.00
- Volume
- 2.46 L
- Prev close
- ₹770.35
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 500Nifty MidSmallcap 400Nifty Smallcap 250
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 10,523 Cr
- Price
- 687.30
- P/E (TTM)
- 41.16
- P/E (Fwd)
- 21.85
- P/B
- 3.18
- EV/EBITDA
- 17.73
- EV/Revenue
- 2.08
- PEG
- —
- Div Yield
- 0.15%
- 52W High
- 714.70
- 52W Low
- 409.30
- Beta
- —
Profitability & income
- Revenue (TTM)
- 4,361 Cr
- Net Income (TTM)
- 255 Cr
- EBITDA
- 511 Cr
- Gross Margin
- 40.62%
- Op. Margin
- 9.84%
- Net Margin
- 5.85%
- ROE
- 8.02%
- ROA
- 4.84%
- EPS (TTM)
- 16.70
- EPS (Fwd)
- 31.46
Financial health
- Total Debt
- 192 Cr
- Total Cash
- 1,681 Cr
- Debt/Equity
- 5.76
- Current Ratio
- 3.25
- Quick Ratio
- 2.26
- Book Value
- 216.41
- Free Cash Flow
- 93 Cr
- Op. Cash Flow
- 1,181 Cr
Growth
- Revenue Growth
- 9.60%
- Earnings Growth
- -42.60%
- Earnings QoQ
- -42.70%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1,158 Cr | 85 Cr | 185 Cr | 112 Cr | 497 Cr | — | 192 Cr | 3,313 Cr |
| 2025-12-31 | 1,160 Cr | 66 Cr | 163 Cr | 107 Cr | 481 Cr | — | — | — |
| 2025-09-30 | 1,018 Cr | 41 Cr | 123 Cr | 57 Cr | 425 Cr | — | 90 Cr | 3,149 Cr |
| 2025-06-30 | 1,024 Cr | 63 Cr | 151 Cr | 92 Cr | 442 Cr | — | — | — |
| 2025-03-31 | 1,056 Cr | 148 Cr | 120 Cr | 54 Cr | 416 Cr | — | 88 Cr | 3,047 Cr |
| 2024-12-31 | — | — | — | — | — | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 4,251 Cr | 255 Cr | 625 Cr | 374 Cr | 1,703 Cr | 1,181 Cr | 192 Cr | 3,313 Cr |
| 2025-03-31 | 4,071 Cr | 338 Cr | 529 Cr | 311 Cr | 1,605 Cr | 465 Cr | 88 Cr | 3,047 Cr |
| 2024-03-31 | 4,020 Cr | -4 Cr | 131 Cr | 360 Cr | 1,437 Cr | 498 Cr | 565 Cr | 709 Cr |
| 2023-03-31 | 3,475 Cr | 95 Cr | 309 Cr | 191 Cr | 1,167 Cr | 177 Cr | 619 Cr | 717 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for AKUMS?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in